UFPT · Ufp Technologies Inc

Track UFPT — free

$290.96 -0.38 (-0.13%)

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$2.26B

7.75M

Volume · Oct 21 18.66K Avg daily vol (3M) 140.56K

Up next

Next earnings call

Nov 3, 2026 Est · unconfirmed · in 2 wks

Latest filing: 10-Q

filed Aug 6, 2026

Q1 2026 earnings call transcript

call held May 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 122 metrics

Revenue (TTM)

$631.64M

Trailing 12 months

Net income (TTM)

$72.30M

Trailing 12 months

Revenue growth YoY

+15.1%

Year over year

Operating margin

15.3%

Trailing 12 months

P / E (TTM)

31.4

Trailing earnings · reciprocal yield 3.2%

FCF yield

—

TTM · current market cap

Return on invested capital

13.8%

Trailing 12 months

Net cash

−$108.26M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+0.2%

Year over year · more shares

Price change (1Y)

+47.7%

Trailing year

Short interest

13.4%

Latest settlement · 9.2 days to cover

View all 122 metrics

Quarterly results

Revenue Net income Net loss

▲44% $145.16M $16.36M '24 Q3 ▲41.9% $144.07M $16.38M '24 Q4 ▲41.1% $148.15M $17.18M '25 Q1 ▲37.2% $151.18M $17.18M '25 Q2 ▲6.5% $154.56M $16.38M '25 Q3 ▲3.4% $148.91M $17.57M '25 Q4 ▲4.1% $154.20M $17.50M '26 Q1 LATEST ▲15.1% $173.96M $20.85M '26 Q2

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol High

Market backdrop VIX 17.3 · elevated Equity put/call 0.56

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg +18%

above

Price vs 50-day avg −2%

below

RSI (14) 49

neutral

MACD trend Negative

52-week position 71%

mid-range

Momentum

relative strength

Very Strong

1-month return +2%

trailing

6-month return +57%

trailing

YTD return +31%

this year

Relative strength +49%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $296 › 200d $248 — 50d above 200d

Institutional flow Distributing

39 of 280 funds reported for Sep 30 · net -255.4K sh shares · +6 new

Insider flow Distributing

Net -$12.6M over 90 days · 100% sells

Short interest Falling

13.39% of float · ▼ -1.6% MoM · 9.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

280 holders — mid 3-yr range

Squeeze score 77

high risk · 0–100

Fundamentals

Strong

Revenue growth +20%

Y/Y

Gross margin 28%

contracting

EPS growth +15%

Y/Y

Free cash flow $82.2M

Valuation P/E 31.4

in line

Buyback $10.0M

authorized

Balance sheet $115.2M

net debt

Quant / Vol

risk profile

High

Volatility 49%

annualized · 1-yr

Max drawdown −31%

past year

ATR 3.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+18% Bullish

Price vs 50-day avg

−2% Neutral

RSI (14)

49 Neutral

MACD trend

Negative Bearish

52-week position

71% Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $296 › 200d $248 — 50d above 200d

Institutional flow Distributing

39 of 280 funds reported for Sep 30 · net -255.4K sh shares · +6 new

Insider flow Distributing

Net -$12.6M over 90 days · 100% sells

Short interest Falling

13.39% of float · ▼ -1.6% MoM · 9.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

280 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $185 Now $291 · 71% Range high $335

vs 200-day avg +18% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDA non-GAAP	$67.3M	six-month period ended June 30, 2026	—
Adjusted EPS non-GAAP	$5.39	six-month period ended June 30, 2026	—
Adjusted net income non-GAAP	$42.1M	six-month period ended June 30, 2026	—
Adjusted net income per diluted share outstanding (Non-GAAP) non-GAAP	$5.39	Six Months Ended June 30, 2026	—
Adjusted operating income non-GAAP	$56.5M	six-month period ended June 30, 2026	—
Adjusted SG&A (Non-GAAP) non-GAAP	$20.28M	Three Months Ended June 30, 2026	—
Adjusted SG&A as a percentage of sales non-GAAP	11.8%	six-month period ended June 30, 2026	—

Balance of MedTech business sales growth	19.7%	second quarter of 2026	—
EBITDA (Non-GAAP) non-GAAP	$61.35M	Six Months Ended June 30, 2026	—
Gross margin	29%	six-month period ended June 30, 2026	—
Organic sales growth non-GAAP	6.8%	six-month period ended June 30, 2026	—

Top five customers sales growth	14.7%	second quarter of 2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
UFPT Ufp Technologies Inc this stock	$2.26B	+31.2%	+19.5%	31.4	13.4%
ABT Abbott Laboratories	$179.20B	-18.2%	+5.7%	33.3	0.8%
MDT Medtronic plc	$121.04B	-1.5%	+8.4%	23.3	3.1%
SYK Stryker Corp	$116.76B	-13.4%	+11.2%	31.5	1.5%
BSX Boston Scientific Corp	$66.02B	-52.2%	+12.5%	18.4	2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

287

% held: 119.7%
Reported: 39 of 280
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

289

View

Short & Settlement

Short Interest Falling

Shares short

1.0M

Days to cover: 9.2d
Change: -16.4K sh

View

Short Volume

Short vol %

45%

As of: Oct 20, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $3.3K
As of: Sep 30, 2026

View

Off-Exchange

Off-exchange %

29.6%

Week of: Sep 14, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$12.6M

Buyers / Sellers: 0 / 5

Buyers Sellers

View

Financials

Revenue (FY)

$602.8M

Net income (FY): $68.3M
EPS diluted: $8.75

View

Buybacks

Authorized

$10.0M

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 24, 2026
This year: 16

View

Proposed Sales

Value

$2.1M

Shares: 7.0K
Filed: Aug 25, 2026

View

Earnings & Events

Webcasts

Last webcast

Aug 4, 2026

View

Performance

	5D	20D	120D	MTD	YTD
UFPT	-1.0%	+2.2%	+57.1%	-1.9%	+31.2%
SPY	-1.2%	-0.6%	+8.1%	+0.8%	+12.8%
vs SPY	+0.2%	+2.7%	+49.0%	-2.7%	+18.4%

Capital returns

Buyback program · as of Jun 16, 2015

Authorized

$10.00M

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 914156 CUSIP 902673102 13F (30d) 41 filings 41 filers Visit website Investor relations

UFPT · Ufp Technologies Inc

Price & Indicators

Up next

Metrics snapshot

Quarterly results

Equibles Rating

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns